Nasal Spotlight

SESSION 4: Nasal Spotlight

Tuesday • May 7, 2024 • 8:30–9:30 AM • Arizona Ballroom
Moderator: Julie D. Suman, Ph.D.

A Dry Powder Platform for Thermostable, Adjuvanted, Nasal Vaccines
Reinhard Vehring
Access to Advanced Health Institute
Targeting the Brain via Intranasal Delivery: Rationale, Progress and Challenges
Daniela Traini
Macquarie University & Woolcock Institute

Discover More

Nasal Powders: Formulation and Device Integration
Dina Morais and Claudia Costa
Hovione
Exploring In Vitro Only Bioequivalence Pathways for Generic Nasal Suspensions
Ben Stafford and Chris Vernall
Intertek
Accelerated Stability and Aerosol Performance Assessment for a Spray Dried Nasal COVID-19 Vaccine Candidate
John Chen
Access to Advanced Health Institute
Process Modeling for Small-Scale Manufacturing of Spray Dried Nasal Vaccine Powders
John Chen
Access to Advanced Health Institute
Optimization of a Multidose Nasal Actuator Targeting Olfactory Region Deposition
Goncalo Farias and Charles Cazzola
Aptar Pharma
Pharmacokinetic Comparison of Nasal Delivered Dry Powdered Epinephrine to an Autoinjector (EpiPen®) in a Canine Model
Brian Taubenheim
Belhaven Biopharma
Using Human Factors Studies to Optimize Nozzle Geometry for Patient Interaction in the Design Development of a Unit Dose Nasal Spray
Sabrina Falloon
Bespak
Systemic Nasal Absorption of Amorphous Solid Dispersions: Supersaturating Systems for Fast Onset of Action of Poorly Soluble Drugs through the Nasal Mucosa
Patricia Henriques and Dina Morais
Hovione
Regulatory Topics in Nasal Product Development: Pediatrics and Reliability Expectations
Svetlana Lyapustina
IPAC-RS
Laser Diffraction Size Analysis of Products for Nasal Inhalation: A Survey of Expert Users
Jolyon Mitchell
IPAC-RS
Manufacturability of Intranasal Dry Powders Spray Dried from Aqueous Solutions
Neerja Zambare and Kimberly Shepard
Lonza
Formulation of an Intranasal Dry Powder Vaccine Candidate for Tuberculosis
Sana Hosseini and Kimberly Shepard
Lonza
Enhancing Nose-to-Brain Drug Delivery: A Comparative Study of Peptide Formulations Using a Multidose Nasal Spray
Chun Yuen Jerry Wong
Macquarie University
Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of Anaphylaxis
Jonas Sävmarker
Orexo AB
Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powders into a Nasal Spray System
Mike Sandoval and Alan Watts
The University of Texas at Austin
Development of an In Vitro Method for In Vivo Prediction of Regional Deposition of Nasal Powders
Nicholas Holtgrewe
U.S. Food & Drug Administration
The Influence of Salts on Spray Dried Powder for Nasal Inhalation: Aerosol Characterization with 3D-Printed Nasal Replica
Han Cong Seow
University of Hong Kong
Successful Scale-Up of a Spray Dried Formulation for Nasal Drug Delivery
Lara Penn
Upperton Pharma Solutions
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS
ORGANIZATIONS
↑ Back to Top